Food Allergy Diagnostics And Therapeutics Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product Type ( Diagnostic Products, Therapeutic Treatment Type ); Allergen Source ( Eggs, Milk, Peanuts, Fish, Soy, Others ); End-User ( Academic Research Institutes, Hospitals and Clinics, Diagnostics Laboratories, Others ) and Geography
Report Code: TIPRE00008965
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
Food Allergy Diagnostics and Therapeutics is indicated for the treatment of advanced prostatic carcinoma in which suppression of testosterone effects is indicated. Food Allergy Diagnostics and Therapeutics may be used in combination with an LHRH agonist, both on commencement of treatment or as an adjunctive therapy in patients already receiving an LHRH agonist. Food Allergy Diagnostics and Therapeutics may also be used in surgically castrated patients.
Increasing incidence of allergic conditions among both pediatric and adult population drives the demand for better therapeutics thereby driving the market growth. According to, American Academy of Pediatrics, 7.6% or an estimated 5.6 million U.S. children have a food allergy and 40% of those children have more than one, about 2.2% of children were allergic to peanut, 1.9% to milk, 1.3% to shellfish, 1.2% to tree nut, 0.9% to egg and 0.6% to fin fish. Moreover technological advancements with the increase in the R&D initiatives by the manufacturers will further offer lucrative opportunities in the market. For instance, introduction of epinephrine auto injector for peanut allergy treatment. However high cost of the products may impede the market growth.
The "Global Food Allergy Diagnostics and Therapeutics Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Food Allergy Diagnostics and Therapeutics Market with detailed market segmentation by product type, allergen source, end-use and geography. The Global Food Allergy Diagnostics and Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Food Allergy Diagnostics and Therapeutics Market players and offers key trends and opportunities in the market.
The Global Food Allergy Diagnostics and Therapeutics Market is segmented on the basis of product type, allergen source, and end-use. Based on product type, the market has been categorized into diagnostic products and therapeutic treatment type. Based on Allergen Source, the Food Allergy Diagnostics and Therapeutics market has been classified into eggs, milk, peanuts, fish, and soy among others. Based on end-user, the Food Allergy Diagnostics and Therapeutics market has been classified into academic research institutes, hospitals & clinics, and diagnostics laboratories among others.?
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Food Allergy Diagnostics and Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Food Allergy Diagnostics and Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Food Allergy Diagnostics and Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Food Allergy Diagnostics and Therapeutics Market in these regions.
Get more information on this report :
The report covers key developments in the Food Allergy Diagnostics and Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Food Allergy Diagnostics and Therapeutics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Food Allergy Diagnostics and Therapeutics Market in the global market. Below mentioned is the list of few companies engaged in the Food Allergy Diagnostics and Therapeutics Market.
The report also includes the profiles of key Food Allergy Diagnostics and Therapeutics Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Allergy Therapeutics
- Cambridge Allergy Ltd
- Astellas Pharma, Inc.
- Immunomic Therapeutics, Inc.
- Prota Therapeutics Pty Ltd
- Aimmune Therapeutics
- ALK-Abello Ltd
- Medeca Pharma AB
- Omega Diagnostics Group
- HYCOR Biomedical
- HOB Biotech Group
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Allergy Therapeutics
2. Cambridge Allergy Ltd
3. Astellas Pharma, Inc.
4. Immunomic Therapeutics, Inc.
5. Prota Therapeutics Pty Ltd
6. Aimmune Therapeutics
8. ALK-Abello Ltd
9. Medeca Pharma AB
11. Omega Diagnostics Group
12. HYCOR Biomedical
13. HOB Biotech Group